Home > Events > Past Conferences > 9th annual Next Generation Pharmaceutical Samples

9th annual Next Generation Pharmaceutical Samples

CBI’s 9th annual Next Generation Pharmaceutical Samples returns as the preeminent forum to discuss best practices in physician sample programs. Benefit from compelling content that addresses the biggest emerging issues in sample programs and chart your program growth for 2019 and beyond. This year’s program will look closely at staff training, data priorities, analytics, audits & inspections, state level regulations, emerging technologies, the changing federal landscape and global sample programs.

Spotlight


OTHER PAST CONFERENCES

4th Annual Pharma AI Summit

October 26-27, 2023 | UK

Artificial Intelligence promises vast opportunities for economic and societal benefits in the pharmaceutical industry, life sciences and healthcare including care delivery with digital health. As data applications supported by AI become more advanced, the whole healthcare value chain has been affected. New forms of drug discoveries and pharma workforces are going to evolve.

PharmSci 360

October 22-25, 2023 | USA

Scientific posters are an essential part of PharmSci 360 and an opportunity to share your research and contribute to the body of pharmaceutical science. They are also a great way to find collaborators, attract recruiters, meet editors, and qualify for awards.

2023 PDA Pharmaceutical Microbiology Conference

October 2-4, 2023 | USA

The 2023 PDA Pharmaceutical Microbiology Conference continues the ongoing tradition of addressing the opportunities and challenges, most relevant, to the future of microbiology in today’s global market.

Advancing Pharmacovigilance Through The Use Of Machine Learning (ml) And Real-world Data (RWD)

November 14-15, 2023 | USA

The objective of this webinar is to discuss both the science and regulatory challenges in two areas of research that have great potential to advance the identification and assessment of drug-related adverse events. ML, a type of artificial intelligence, is showing promise as a tool to enhance drug causality assessments, among other areas in the PV life cycle.

4th Annual Pharma AI Summit

October 26-27, 2023 | UK

Artificial Intelligence promises vast opportunities for economic and societal benefits in the pharmaceutical industry, life sciences and healthcare including care delivery with digital health. As data applications supported by AI become more advanced, the whole healthcare value chain has been affected. New forms of drug discoveries and pharma workforces are going to evolve.

PharmSci 360

October 22-25, 2023 | USA

Scientific posters are an essential part of PharmSci 360 and an opportunity to share your research and contribute to the body of pharmaceutical science. They are also a great way to find collaborators, attract recruiters, meet editors, and qualify for awards.

2023 PDA Pharmaceutical Microbiology Conference

October 2-4, 2023 | USA

The 2023 PDA Pharmaceutical Microbiology Conference continues the ongoing tradition of addressing the opportunities and challenges, most relevant, to the future of microbiology in today’s global market.

Advancing Pharmacovigilance Through The Use Of Machine Learning (ml) And Real-world Data (RWD)

November 14-15, 2023 | USA

The objective of this webinar is to discuss both the science and regulatory challenges in two areas of research that have great potential to advance the identification and assessment of drug-related adverse events. ML, a type of artificial intelligence, is showing promise as a tool to enhance drug causality assessments, among other areas in the PV life cycle.
More Past Conferences

Spotlight

resources

resource image

How long will the world wait for the next pandemic of antimicrobial resistance before we act?

Article

resource image

Driving Down Drug Costs: How Real-Time Transparency in PBMs Can Make a Difference

Article